Filing Details

Accession Number:
0001415889-22-003280
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-23 16:05:13
Reporting Period:
2021-11-03
Accepted Time:
2022-03-23 16:05:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1597264 Blueprint Medicines Corp BPMC Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1756941 Christina Rossi C/O Blueprint Medicines Corporation
45 Sidney Street
Cambridge MA 02139
Chief Commercial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-11-03 511 $110.85 43,968 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
  2. The amount of securities beneficially owned by the Reporting Person, as reported in Forms 4 filed by the Reporting Person subsequent to the Transaction Date but prior to the date of this Form 4, did not reflect this sell to cover transaction.